Post-emergency department management of stroke

Emergency Medicine Clinics of North America

Volumn 20, Issue 3, 2002, Pages 687-702

  Brown, Devin L ^a   Haley, E Clarke ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CLOPIDOGREL; DIPYRIDAMOLE; ENALAPRILAT; FIBRINOLYTIC AGENT; FUROSEMIDE; GLUCOSE; HEPARIN; LABETALOL; MANNITOL; NITROPRUSSIDE SODIUM; PHENYTOIN; PROUROKINASE; RECOMBINANT PLASMINOGEN ACTIVATOR; STEROID; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ANTICOAGULANT THERAPY; ASPIRATION PNEUMONIA; BLEEDING; BLOOD PRESSURE REGULATION; BRAIN EDEMA; BRAIN ISCHEMIA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; FEVER; FIBRINOLYTIC THERAPY; HEPARINIZATION; HOSPITAL DISCHARGE; HUMAN; HYPOXEMIA; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; OXYGEN THERAPY; PRIORITY JOURNAL; REVIEW; SEIZURE; STROKE; URINARY TRACT INFECTION;

EID: 0036696557     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/S0733-8627(02)00018-4     Document Type: Review

References (70)

1. Stroke unit trialists' collaboration. Collaborative systemic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Br Med J 1997;314:1151-9.
2. The National Institute of Neurologic Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-7.
3. Albers GW, Bates VE, Clark WM, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000;283:1145-50.
4. Adams Jr HP, Brott TG, Furlan A, et al. Guidelines for thrombolytic therapy for acute stroke. A supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council. American Heart Association. Stroke 1996;27:1711-8.
5. The International Stroke Trial (IST). A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group. Lancet 1997;349:1569-81.
6. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997;349:1641-9.
7. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-11.
8. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA Stroke Study. Neurology 2000;55:1649-55.
9. Duke RJ, Bloch RF, Turpie AG, et al. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke. Ann Intern Med 1986;105:825-8.
10. Haley Jr EC, Kassell NF, Torner JC. Failure of heparin to prevent progression in progressing ischemic infarction. Stroke 1988;19:10-4.
11. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke. A randomized trial. Stroke 1983;14:668-76.
12. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid. ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. JAMA 1998;279: 1265-72.
13. Kay R, Wong KS, Yu YL, et al. Low-molecular weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333:1588-93.
14. Adams Jr HP, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council. American Heart Association. Circulation 1994;90:1588-601.
15. Ronning OMG, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke 1999;30:2033-7.
16. Dirnagl U, Pulsinelii W. Autoregulation of cerebral blood flow in experimental focal brain ischemia. J Cereb Blood Flow Metab 1990;10:327-36.
17. Fieschi C, Agnoli A, Battistini N, et al. Derangement of regional cerebral blood flow and of its regulatory mechanisms in acute cerebrovascular lesions. Neurology 1968;18:1166-79.
18. Lisk DR, Grotta JC, Lamki LM, et al. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol 1993;50:855-62.
19. Brott T, Lu M, Kothari R, et al. Hypertension and its treatment in the NINDS rt-PA stroke trial. Stroke 1998;29:1504-9.
20. Pulsinelli WA, Waldman S, Rawlinson D, et al. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 1982;32:1239-46.
21. Yip PK, He YY, Hsu CY, et al. Effect of plasma glucose on infarct size in focal cerebral ischemia-reperfusion. Neurology 1991;41:899-905.
22. 2 modulation of cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 1999;30:160-70.
23. Hamilton MG, Tranmer BI, Auer RN. Insulin reduction of cerebral infarction due to transient focal ischemia. J Neurosurg 1995;82:262-8.
24. Bruno A, Biller J, Adams Jr HP, et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology 1999;52:280-4.
25. Pulsinelli WA, Levy DE, Sigsbee B, et al. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes. Am J Med 1983;74:540-4.
26. Azzimondi G, Bassein L, Nonino F, et al. Fever in acute stroke worsens prognosis: a prospective study. Stroke 1995;26:2040-3.
27. Castillo J, Davalos A, Marrugat J, et al. Timing for fever-related brain damage in acute ischemic stroke. Stroke 1998;29:2455-60.
28. Ginsberg MD, Busto R. Combating hyperthermia in acute stroke: a significant clinical concern. Stroke 1998;29:529-34.
29. Globus MY, Busto R, Lin B, et al. Detection of free radical activity during transient global ischemia and recirculation: effects of intraischemic brain temperature modulation. J Neurochem 1995;65:1250-6.
30. Monda MV, Viggiano A, Sullo A, et al. Aspartic and glutamic acids increase in the frontal cortex during prostaglandin E1 hyperthermia. Neuroscience 1998;83:1239-43.
31. Becker K. Intensive care unit management of the stroke patient. Neurol Clin 2000;18:439-54.
32. Berrouschot J, Rossler A, Koster J, et al. Mechanical ventilation in patients with hemispheric ischemic stroke. Crit Care Med 2000;28:2956-61.
33. Talmor D, Shapira Y, Artru AA, et al. 0.45% saline and 5% dextrose in water, but not 0.9% saline or 5% dextrose in 0.9% saline, worsen brain edema two hours after closed head trauma in rats. Anesth Analg 1998;86:1225-9.
34. Kelly J, Rudd A, Lewis R, et al. Venous thromboembolism after acute stroke. Stroke 2001;32:262-7.
35. Prevention of venous thrombosis and pulmonary embolism. JAMA 1986;256:744-9.
36. Landi G, D'Angelo A, Boccardi E, et al. Venous thromboembolism in acute stroke. Stroke 1992;49:279-83.
37. Warlow C, Ogston D, Douglas AS. Deep venous thrombosis of the legs after strokes. Br Med J 1976;1:1178-83.
38. Kamran SI, Downey D, Ruff RL. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients. Neurology 1998;50:1683-8.
39. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet 2000;355:1295-302.
40. Johnston KC, Li JY, Lyden PD, et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. Stroke 1998; 29:447-53.
41. Mann G, Hankey GJ, Cameron D. Swallowing function after stroke: prognosis and prognostic factors at 6 months. Stroke 1999;30:744-8.
42. Davalos A, Ricart W, Gonzalez-Huix F, et al. Effect of malnutrition after acute stroke on clinical outcome. Stroke 1996;27:1028-32.
43. Smithard DG, O'Neill PA, Park C, et al. Complications and outcome after acute stroke. Does dysphagia matter? Stroke 1996;27:1200-4.
44. Davenport RJ, Dennis MS, Wellwood I, et al. Complications after acute stroke. Stroke 1996;27:415-20.
45. Caplan LR, Sergay S. Positional cerebral ischaemia. J Neurol Neurosurg Psychiatry 1976; 39:385-91.
46. Moraine JJ, Berre J, Melot C. Is cerebral perfusion pressure a major determinant of cerebral blood flow during head elevation in comatose patients with severe intracranial lesions? J Neurosurg 2000;92:606-14.
47. Stieg PE, Kase CS. Intracranial hemorrhage: diagnosis and emergency management. Neurol Clin N Am 1998;16:373-90.
48. Fortune JB, Feustel PJ, Graca L, et al. Effects of hyperventilation, mannitol, and ventriculostomy drainage on cerebral blood flow after head injury. J Trauma 2001;39:1091-9.
49. Burke AM, Quest DO, Chien. The effects of mannitol on blood viscosity. J Neurosurg 1981;55:550-3.
50. Muizelaar JP, Wei EP, Kontos HA, et al. Mannitol causes compensatory cerebral vasoconstriction and vasodilation in response to blood viscosity changes. J Neurosurg 1983;59:822-8.
51. Marshall LF, Smith RW, Rauscher LA, et al. Mannitol dose requirements in brain-injured patients. J Neurosurg 1978;48:169-72.
52. James HE, Langfitt TW, Kumar VS, et al. Treatment of intracranial hypertension. Analysis of 105 consecutive, continuous recordings of intracranial pressure. Acta Neurochir (Wien) 1977;36:189-200.
53. Schwab S, Steiner T, Aschoff A, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998;29:1888-93.
54. Delashaw JB, Broaddus WC, Kassell NF, et al. Treatment of right hemispheric cerebral infarction by hemicraniectomy. Stroke 1990;21:874-81.
55. Chen HJ, Lee TC, Wei CP. Treatment of cerebellar infarction by decompressive suboccipital craniectomy. Stroke 1992;23:957-61.
56. Norris JW, Hachinski VC. High dose steroid treatment in cerebral infarction. Br Med J Clin Res 1986;292:21-3.
57. Norris JW. Steroid therapy in acute cerebral infarction. Arch Neurol 1976;33:69-71.
58. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizure after stroke: a prospective multicenter study. Arch Neurol 2000;57:1617-22.
59. Velioglu SK, Özmenoglu M, Boz C, et al. Status epilepticus after stroke. Stroke 2001; 32:1169-72.
60. Hornig CR. Hemorrhagic cerebral infarction-a prospective study. Stroke 1986;17:179-85.
61. Culebras A, Kase C, Masdeu JC, et al. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke: a report of the Stroke Council. American Heart Association. Stroke 1997;28:1480-97.
62. Hass WK, Easton JD, Adams Jr HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group. N Engl J Med 1989;321:501-7.
63. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39.
64. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
65. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study. Circulation 1991;84:527-49.
66. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-53.
67. Barnett HJ, Taylor DW, Eliasziw M, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998;339:1415-25.
68. Freburger JK. Analysis of the relationship between the utilization of physical therapy services and outcomes for patients with acute stroke. Phys Ther 1999;79:906-18.
69. Liepert J, Bauder H, Wolfgang HR, et al. Treatment-induced cortical reorganization after stroke in humans. Stroke 2000;31:1210-6.
70. Schwab S, Aschoff A, Spranger M, et al. The value of intracranial pressure monitoring in acute hemispheric stroke. Neurology 1996;47:393-8.